Abstract:High-risk human papillomavirus (HPV)16/18 infection in the development of lung cancer has previously been identified, and fragile histidine triad (FHIT) loss and p53 mutation are frequently observed in the disease. However, the association between these factors has not been well studied. The present study aimed to further investigate the significance of HPV infection, FHIT loss and p53 mutations in the development of lung cancer and their possible associations. DNA was extracted from paraffin-embedded specimens from 88 cases of squamous cell carcinoma (SCC), 56 of adenocarcinoma (AC), 36 of small cell lung carcinoma (SCLC) and 110 non-cancer control cases of lung neoplasms. The prevalence of HPV infection was determined by polymerase chain reaction analysis, and FHIT loss and p53 mutations were detected by immunohistochemistry. The (2), Fisher's exact and Pearson correlation tests were applied for statistical analysis. The results of the present study demonstrated that HPVL1 (the major capsid protein of HPV), HPV16 and HPV18 infection were more prevalent in the lung cancer samples compared with the non-cancer controls (all P<0.001). FHIT loss occurred more frequently in the lung cancer samples (44.44%) compared with the non-cancer controls (7.25%) (P<0.001). FHIT loss in the HPVL1-positive group was significantly increased compared with the HPVL1-negative group in the lung cancer cases and the non-cancer controls (P<0.05). In the lung cancer cases, the p53 mutation rates in the HPVL1- and HPV16/18-positive groups were significantly increased compared with the HPVL1- and HPV16/18-negative groups (P<0.05). In the 180 lung cancer cases, the coexistence rate of FHIT loss and a history of smoking was 38.33% (69/180; Pearson contingency coefficient of r=0.318; P<0.001). FHIT loss and p53 mutation exhibited a synergistic effect on HPV-associated lung cancer (Pearson contingency coefficient r=0.357, P<0.001). The present study demonstrated that FHIT loss may be important in the occurrence of lung cancer, particularly in lung SCCs. FHIT loss may therefore be used as an early indicator for lung cancer, particularly for patients with a history of smoking. HPV infection in lung tumorigenesis may, at least in part, be mediated through FHIT loss. FHIT loss and p53 mutation may coordinate together in the development of HPV-associated lung cancer, and accelerate the occurrence and development of lung cancer.

Study on the microsatellite instability and protein expression of FHIT gene in breast cancer

Regulation of Dna Methylation on the Expression of the Fhit Gene Contributes to Cervical Carcinoma Cell Tumorigenesis

The Expression of FHIT Protein in Progression of Breast Carcinoma

Identification of IFITM1 with prognostic value in pancreatic cancer using network module-based analysis

Involvement of genetic instability in the downregulation of sFRP1 in Chinese patients with hepatocellular carcinoma.

Expressions of FATI0 and P53 Mutant in Human Gastric Cancer and Their Relations

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer

Expression of Fragile Histidine Triad in Primary Hepatocellular Carcinoma and Its Relation with Cell Proliferation and Apoptosis

The Clinicopathological Significance and Drug Target Potential of FHIT in Breast Cancer, a Meta-Analysis and Literature Review.

Expression of FHIT Gene in Gastric Cancer and Relationship with Proliferation of Tumor Cell

Upregulation of FHIT Gene Expression in Endometrial Carcinoma by RNA Activation.

FAT10 Level in Human Gastric Cancer and Its Relation with Mutant P53 Level, Lymph Node Metastasis and TNM Staging.

Study of mRNA Expressions of FHIT Genes in Patients with Non- small Cell Lung Cancer

Expression of FHIT Protein,ki-67 and Their Significance in Endometrial Carcinoma

[Allelic Loss and Down-Regulation of FHIT Gene Expression in Esophageal Squamous Cell Carcinoma].

Homozygous Deletion and Mutation of Antioncogene FHIT Gene Exon 5 and Exon 8 in Gastric Carcinoma

The Significance and Relationship Between the Expressions of FHIT Gene and HER_2 in Non-Small Cell Lung Cancer

Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development

Fragile histidine triad transcription abnormalities and human papillomavirus16 infection in human cervical carcinoma

Research Progress on Relationship among Microsatellite Instability, HMLH1, FHIT Gene and Gastric Carcinoma

Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.